Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesDividends payablesLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Pharma-Bio Serv (PBSV) Other Non-Current Assets (2016 - 2026)

Pharma-Bio Serv's Other Non-Current Assets history spans 16 years, with the latest figure at $120783.0 for Q1 2026.

  • For Q1 2026, Other Non-Current Assets fell 46.45% year-over-year to $120783.0; the TTM value through Jan 2026 reached $120783.0, down 46.45%, while the annual FY2025 figure was $120754.0, 46.47% down from the prior year.
  • Other Non-Current Assets reached $120783.0 in Q1 2026 per PBSV's latest filing, roughly flat from $120754.0 in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $353294.0 in Q1 2022 to a low of $111665.0 in Q4 2023.
  • Average Other Non-Current Assets over 5 years is $174368.5, with a median of $130874.0 recorded in 2022.
  • Peak YoY movement for Other Non-Current Assets: plummeted 63.14% in 2023, then surged 102.06% in 2025.
  • A 5-year view of Other Non-Current Assets shows it stood at $130874.0 in 2022, then decreased by 14.68% to $111665.0 in 2023, then skyrocketed by 102.03% to $225599.0 in 2024, then crashed by 46.47% to $120754.0 in 2025, then grew by 0.02% to $120783.0 in 2026.
  • Per Business Quant, the three most recent readings for PBSV's Other Non-Current Assets are $120783.0 (Q1 2026), $120754.0 (Q4 2025), and $225649.0 (Q3 2025).